All FDA Articles
-
1.3KLatest Myopia NewsiVeena Completes Pre-IND FDA Meeting
November 11, 2021 SALT LAKE CITY — iVeena Delivery Systems announced that the company has successfully completed a pre-IND (Investigational New Drug)...
-
3.0KLatest Myopia NewsEssilor’s Stellest Lenses Receive FDA Breakthrough Device Designation
May 17, 2021 CHARENTON-LE-PONT, France — The U.S. Food and Drug Administration (FDA) granted Essilor’s Stellest lenses the Breakthrough Device designation. With...
-
5.0KLatest Myopia NewsJohnson & Johnson Vision’s ACUVUE Abiliti OrthoK Receives FDA Approval
May 12, 2021 JACKSONVILLE, Fla. — The U.S. Food and Drug Administration (FDA) has approved ACUVUE Abiliti Overnight Therapeutic Lenses, Johnson &...
-
7.7KLatest Myopia NewsJohnson & Johnson Vision Receives FDA’s Breakthrough Device Designation for Myopia Control Lens
July 17, 2020 Johnson & Johnson Vision has received FDA’s Breakthrough Device designation for its myopia control lens, Chris DelOrefice, Johnson &...
-
3.8KPatient CommunicationExplaining “Off Label” to Parents
Balance the risks of using an off-label treatment with the eye health consequences of no treatment at all.
-
2.2KLatest Myopia NewsMyopia Management Focus of Pipeline Expansion for Leo Lens Pharma
SAN DIEGO – Leo Lens Pharma has received a notice of allowance from the U.S. Patent and Trade Office for a patent...
-
5.5KEditor’s PerspectiveMiSight® 1 Day FDA Approval: Why It Matters
MiSight® 1 day’s FDA approval is an important step forward in stopping the myopia epidemic facing American children.
-
3.3KLatest Myopia NewsC&E GP Specialists Inc. Awarded ISO 13485:2016 Certificate
Nov. 15, 2019 San Diego, Calif. – C&E GP Specialists Inc., a leading manufacturer of orthokeratology specialty rigid gas-permeable contact lenses, has...